Tsai H.-Y.LI-MIN HUANGShih Y.-T.JONG-MIN CHENJiang T.-M.Tsai C.-H.CHIN-YUN LEE2021-06-242021-06-2419990882-8245https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033403150&doi=10.1089%2fvim.1999.12.343&partnerID=40&md5=cc19202da52e9bfe60549e7977e8c17dhttps://scholars.lib.ntu.edu.tw/handle/123456789/566686[SDGs]SDG3measles vaccine; antibody response; article; clinical trial; controlled clinical trial; controlled study; coughing; diarrhea; drug efficacy; drug safety; female; fever; human; immunogenicity; infant; major clinical study; male; measles; Measles virus; randomized controlled trial; rash; rhinorrhea; seroconversion; strain difference; vaccine productionImmunogenicity and safety of standard-titer AIK-C measles vaccine in nine-month-old infantsjournal article10.1089/vim.1999.12.3432-s2.0-0033403150